Rick S. Kent

Rick S.
Kent currently works at Esanex, Inc., as Director, Innocrin Pharmaceuticals Holdings LLC, as Director, Vascular Pharmaceuticals, Inc., as Director, and Innocrin Pharmaceuticals, Inc., as Director.
Dr. Kent also formerly worked at Serenex, Inc., as President & Chief Executive Officer from 2002 to 2007, Ardent Pharmaceuticals, Inc., as President & Chief Executive Officer in 2002, Aldagen, Inc., as Chairman from 2010 to 2012, Nuo Therapeutics, Inc., as Independent Director from 2012 to 2014, Inspire Pharmaceuticals, Inc., as Director from 2004 to 2011, Cempra Pharmaceuticals, Inc., as Director, CSA Medical, Inc., as Director, Cempra, Inc., as Director from 2010 to 2011, Glaxo Wellcome, Inc., as VP-US Medical Affairs & Group Medical Director from 1998 to 2001, Burroughs Wellcome, as International Director-Medical Research, GSK Plc, as Chief Medical Officer & SVP-Global Medical Affairs, and Duke University, as Member-Medical Faculty.
Dr. Kent received his undergraduate degree from the University of California, Berkeley and doctorate degree from the University of California San Diego.